GENEVA, Oct. 1 -- AVALYN PHARMA INC. filed a patent application (US2026/018597) for “INHALED NINTEDANIB (AP02) FOR IDIOPATHIC PULMONARY FIBROSIS”. With publication no. WO/2026/193088, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/496
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....